Therapy Areas: Oncology
20 November 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, announced on Friday that the Phase 3 TroFuse-015 trial evaluating investigational dr...
20 November 2026 - Biotechnology company BioMimetix JV LLC announced on Thursday the publication of results from a multicentre Phase I/II clinical trial evaluating BMX-001, a redox-active metalloporph...
19 November 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, announced on Thursday that it has entered into a strategic research collaboration wi...
19 November 2026 - Life sciences company Avacta Therapeutics (AIM:AVCT) on Thursday reported new preclinical data showing that its investigational cancer drug AVA6207 overcame resistance to topoisomer...
19 November 2026 - Biotechnology company Anixa Biosciences Inc (NASDAQ:ANIX) announced on Wednesday that it will work with Curia Global, a contract development and manufacturing organisation (CDMO), t...
19 November 2026 - DNV, an EU Notified Body for the In Vitro Diagnostic Medical Devices Regulation (IVDR), announced on Wednesday that it has issued an IVDR certificate to China-based FAMID Biomedical...